Correlation Between Equillium and Lexeo Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Equillium and Lexeo Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Lexeo Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equillium and Lexeo Therapeutics, Common, you can compare the effects of market volatilities on Equillium and Lexeo Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Lexeo Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Lexeo Therapeutics,.

Diversification Opportunities for Equillium and Lexeo Therapeutics,

-0.33

Correlation Coefficient

Equillium  Lexeo Therapeutics,

Very good diversification

The 3 months correlation between Equillium and Lexeo is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Lexeo Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexeo Therapeutics, and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Lexeo Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexeo Therapeutics, has no effect on the direction of Equillium i.e., Equillium and Lexeo Therapeutics, go up and down completely randomly.

Pair Corralation between Equillium and Lexeo Therapeutics,

Allowing for the 90-day total investment horizon Equillium is expected to generate 0.84 times more return on investment than Lexeo Therapeutics,. However, Equillium is 1.18 times less risky than Lexeo Therapeutics,. It trades about -0.05 of its potential returns per unit of risk. Lexeo Therapeutics, Common is currently generating about -0.05 per unit of risk. If you would invest  74.00  in Equillium on December 28, 2024 and sell it today you would lose (25.00) from holding Equillium or give up 33.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Equillium  vs.  Lexeo Therapeutics, Common

Equillium

Risk-Adjusted Performance

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Lexeo Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lexeo Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Equillium and Lexeo Therapeutics,

The main advantage of trading using opposite Equillium and Lexeo Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Lexeo Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexeo Therapeutics, will offset losses from the drop in Lexeo Therapeutics,'s long position.

The idea behind Equillium and Lexeo Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.